Travelers' diarrhea: an update on susceptibility, prevention, and treatment.
Traditional risk factors do not explain the individual differences in susceptibility to travelers' diarrhea (TD) among the increasing number of travelers to the developing world. Single-nucleotide polymorphisms of the genes encoding for lactoferrin and interleukin 8 (IL-8) have been linked to susceptibility to TD. Subjects with mutations of the FUT2 gene are immune to norovirus infection. The recognition of individual variations in susceptibility to TD will aid in risk stratification of travelers to the developing world. Diagnosis is usually syndromic, but improved diagnostic methods are in development. Quinolones have been the mainstay of antibiotic treatment, but azithromycin (for resistant organisms) and rifaximin (for noninvasive organisms) may provide advantages. Transcutaneous vaccines for the major Escherichia coli enteropathogens are in development. In the future, travel advice, prophylactic medication regimens, and standby treatment for TD will be better tailored to each patient's specific risk factors.
Cabada
Miguel M
MM
Infectious Disease Division, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA.
White
A Clinton
AC
D003967:Diarrhea / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy*; D004198:Disease Susceptibility; D006801:Humans; D016209:Interleukin-8 / Q000502:physiology; D014195:Travel
D016209:Interleukin-8
J Travel Med. 2004 Jul-Aug;11(4):231-7
15541226
Clin Infect Dis. 2003 Nov 1;37(9):1165-71
14557959
JAMA. 1983 Mar 4;249(9):1176-80
6823079
Nat Med. 2003 May;9(5):548-53
12692541
BMJ. 1994 Jan 15;308(6922):176
7906170
J Clin Microbiol. 2005 Mar;43(3):1112-7
15750070
J Infect Dis. 2002 Feb 15;185(4):497-502
11865402
J Infect Dis. 2003 Jan 1;187(1):87-95
12508150
Annu Rev Immunol. 2007;25:787-820
17291188
J Travel Med. 2007 Sep-Oct;14(5):312-9
17883462
PLoS One. 2008 Mar 19;3(3):e1833
18350168
Am J Trop Med Hyg. 2006 Nov;75(5):968-72
17123998
Clin Infect Dis. 2008 Jun 15;46(12):1881-3
18462105
Clin Infect Dis. 2007 Feb 1;44(3):338-46
17205438
Clin Microbiol Infect. 2007 Oct;13(10):1001-7
17714523
Gastroenterology. 2002 Jun;122(7):1967-77
12055602
Clin Infect Dis. 2005 Dec 1;41 Suppl 8:S531-5
16267714
Biometals. 2004 Jun;17(3):189-96
15222464
J Clin Microbiol. 2007 Oct;45(10):3295-301
17687011
Ann Intern Med. 2005 May 17;142(10):805-12
15897530
J Gastroenterol Hepatol. 2002 Dec;17(12):1291-8
12423274
J Infect Dis. 2008 Feb 1;197(3):474-8
18248305
J Infect Dis. 2002 Apr 1;185(7):944-9
11920319
J Clin Microbiol. 2007 Nov;45(11):3620-5
17728475
Infect Immun. 2007 May;75(5):2163-70
17261601
BMJ. 1996 Feb 17;312(7028):414-5
8601113
Nature. 1994 Apr 7;368(6471):502
8139683
J Infect Dis. 2003 Aug 15;188(4):506-11
12898436
Biometals. 2004 Jun;17(3):225-9
15222469
Clin Gastroenterol Hepatol. 2007 Apr;5(4):451-6
17382603
J Clin Invest. 2008 Apr;118(4):1277-90
18382740
J Clin Microbiol. 2008 May;46(5):1752-7
18322059
J Med Microbiol. 2006 Sep;55(Pt 9):1265-1270
16914658
Infect Immun. 2008 Feb;76(2):639-45
18025100
Am J Gastroenterol. 2006 May;101(5):1112-6
16573784
Infect Immun. 1999 Mar;67(3):1471-80
10024597
J Infect Dis. 2004 Feb 1;189(3):520-6
14745711
Hum Mol Genet. 2005 Jul 15;14(14):2045-52
15944200
Am J Trop Med Hyg. 2006 Jun;74(6):1060-6
16760520
Clin Gastroenterol Hepatol. 2007 Aug;5(8):964-8
17618838
Vaccine. 2007 May 4;25(18):3684-91
17313998
N Engl J Med. 2006 Feb 9;354(6):610-21
16467548
Am J Trop Med Hyg. 2000 Jun;62(6):711-3
11304060
Am J Hum Genet. 2003 Sep;73(3):591-600
12916016
Basic Clin Pharmacol Toxicol. 2005 Feb;96(2):94-102
15679471
Clin Infect Dis. 2007 Apr 1;44(7):945-52
17342646
J Biol Chem. 2004 May 7;279(19):19902-7
14990585